The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.
Xtandi, Astellas’ roughly $6 billion prostate cancer juggernaut by annual sales, is set to lose U.S. patent protection in ...
Everyday Health on MSN
How palliative care can boost your quality of life if you have metastatic bladder cancer
Discover a comprehensive palliative care plan designed to enhance quality of life for those with metastatic bladder cancer.
The regulator’s Office of Prescription Drug Promotion (OPDP) has already sent out two letters alleging “false or misleading” ...
ANKTIVA® sales momentum continues to trend upward with full year preliminary net product revenue of approximately $113.0 ...
MedPage Today on MSN
Color Blindness and Bladder Cancer: A Bad Combination for Survival?
A retrospective cohort study suggested that people with color blindness may have a higher risk of mortality from bladder ...
Urology departments in England and Wales have reported seeing an increase in the number of 16- to 24-year-olds being admitted ...
ImmunityBio (IBRX) stock rises as the company records over 400% YoY groiwth in Q4 net product revenue thanks to its cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback